OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/22 VoxNeuro is giving the brain a voice through cognitive health assessment Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 Winterlight Labs announces data demonstrating the sensitivity of speech-based digital measures in detecting longitudinal change in Alzheimer’s disease in collaboration with Genentech Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure Read More OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 Immugenia Obtains Pre-Seed Funding from adMare BioInnovations, ACET Capital, and Sherbrooke Innopole to Develop a Cancer Treatment Which Would Prevent Relapses Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/27/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/27/22 Oncoustics AI and UHN Awarded OBIO® Early Adopter Health Network Grant to Trial Point of Care Liver Assessment Solutions in Clinic Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/22 Zucara Therapeutics' Positive Proof-of-Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01 Read More OBIO News, Press Releases Doriane Rey 9/14/22 OBIO News, Press Releases Doriane Rey 9/14/22 Oncoustics AI and UHN Awarded OBIO® Early Adopter Health Network Grant to Trial Point of Care Liver Assessment Solutions in Clinic Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/22 VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease Read More OBIO News, Ontario Industry Updates Arsheen Kaur 9/12/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/12/22 Linamar MedTech Achieves ISO 13485 Certification for Medical Device Manufacturing Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/30/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/30/22 Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC) Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 Oncoustics Secures $5.5 Million CAD to Help Spot Liver Disease Using AI Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 Allarta Team behind breakthrough research that aims to cure diabetes Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/19/22 OBIO News, Ontario Industry Updates Arsheen Kaur 7/19/22 Spiderwort secures $13.2M USD in Series A Financing to Accelerate Clinical Trials of Revolutionary Biomaterials Read More OBIO News, Press Releases Doriane Rey 7/11/22 OBIO News, Press Releases Doriane Rey 7/11/22 Increasing the Adoption of Canadian Innovations and Focusing on Women’s Leadership/Accroître l’adoption des innovations canadiennes et mettre à l’honneur le leadershipdes femmes Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 ABOzymes Completes Seed Financing Round to Fund Development of Technology to Enable Universal Organ Transplants and Blood Transfusions Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1 Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Ovensa and Celanese Explore Collaborative Innovation to Advance Precision Drug Delivery and Therapeutic Outcomes Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Cyclica and Oncocross Announce Partnership to Develop Therapeutics in Oncology Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics Read More OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Proof-of-Concept Trial Confirms ZT-01’s Mechanism of Action in Restoring Glucagon Release in Patients with Type 1 Diabetes Read More Newer Posts Older Posts
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/22 VoxNeuro is giving the brain a voice through cognitive health assessment Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 Winterlight Labs announces data demonstrating the sensitivity of speech-based digital measures in detecting longitudinal change in Alzheimer’s disease in collaboration with Genentech Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/22 Immugenia Obtains Pre-Seed Funding from adMare BioInnovations, ACET Capital, and Sherbrooke Innopole to Develop a Cancer Treatment Which Would Prevent Relapses Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/27/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/27/22 Oncoustics AI and UHN Awarded OBIO® Early Adopter Health Network Grant to Trial Point of Care Liver Assessment Solutions in Clinic Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/22 Zucara Therapeutics' Positive Proof-of-Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01 Read More
OBIO News, Press Releases Doriane Rey 9/14/22 OBIO News, Press Releases Doriane Rey 9/14/22 Oncoustics AI and UHN Awarded OBIO® Early Adopter Health Network Grant to Trial Point of Care Liver Assessment Solutions in Clinic Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/22 VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/12/22 OBIO News, Ontario Industry Updates Arsheen Kaur 9/12/22 Linamar MedTech Achieves ISO 13485 Certification for Medical Device Manufacturing Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/30/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/30/22 Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC) Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 Oncoustics Secures $5.5 Million CAD to Help Spot Liver Disease Using AI Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 OBIO News, Ontario Industry Updates Arsheen Kaur 8/2/22 Allarta Team behind breakthrough research that aims to cure diabetes Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/19/22 OBIO News, Ontario Industry Updates Arsheen Kaur 7/19/22 Spiderwort secures $13.2M USD in Series A Financing to Accelerate Clinical Trials of Revolutionary Biomaterials Read More
OBIO News, Press Releases Doriane Rey 7/11/22 OBIO News, Press Releases Doriane Rey 7/11/22 Increasing the Adoption of Canadian Innovations and Focusing on Women’s Leadership/Accroître l’adoption des innovations canadiennes et mettre à l’honneur le leadershipdes femmes Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 ABOzymes Completes Seed Financing Round to Fund Development of Technology to Enable Universal Organ Transplants and Blood Transfusions Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1 Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Ovensa and Celanese Explore Collaborative Innovation to Advance Precision Drug Delivery and Therapeutic Outcomes Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Cyclica and Oncocross Announce Partnership to Develop Therapeutics in Oncology Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics Read More
OBIO News Arsheen Kaur 7/5/22 OBIO News Arsheen Kaur 7/5/22 Proof-of-Concept Trial Confirms ZT-01’s Mechanism of Action in Restoring Glucagon Release in Patients with Type 1 Diabetes Read More